Ordinary Rebalance | Solactive Future Pharmaceutical Europe Index | 7th September 2022

In the ordinary rebalance the following composition will be implemented effective open 07.09.2022:

ARGENX SE
ASTRAZENECA PLC
BAYER AG
GENMAB A/S
GSK PLC
IPSEN SA
LONZA GROUP AG
MERCK KGAA
NOVARTIS AG
NOVO NORDISK A/S
RECORDATI SPA
ROCHE HOLDING AG
SANOFI SA
SARTORIUS AG PREF
UCB SA